Continue to site >
Trending ETFs

Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Invenomic Fund

BIVRX | Fund

$18.01

$1.44 B

0.00%

3.33%

Vitals

YTD Return

-6.8%

1 yr return

-2.7%

3 Yr Avg Return

24.7%

5 Yr Avg Return

25.2%

Net Assets

$1.44 B

Holdings in Top 10

26.0%

52 WEEK LOW AND HIGH

$17.8
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 3.33%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 179.00%

Redemption Fee 1.00%


Min Investment

Standard (Taxable)

$5,000

IRA

$1,000


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Invenomic Fund

BIVRX | Fund

$18.01

$1.44 B

0.00%

3.33%

BIVRX - Profile

Distributions

  • YTD Total Return -6.8%
  • 3 Yr Annualized Total Return 24.7%
  • 5 Yr Annualized Total Return 25.2%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.56%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name
    Invenomic Fund
  • Fund Family Name
    Balter
  • Inception Date
    Jun 19, 2017
  • Shares Outstanding
    N/A
  • Share Class
    Investor
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Ali Motamed

Fund Description

The Fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short portfolio to fluctuate based on the market opportunity.

The long positions are identified by the Fund’s adviser, Invenomic Capital Management, LP (the “Adviser”) as securities that are both undervalued and timely, where the Adviser believes that the return potential compensates for the risk involved. The short positions are identified as securities that the Adviser believes are overvalued and that the price of the security will fall, delivering both a positive return for the Fund while simultaneously reducing the overall risk of the portfolio. The Adviser evaluates long and short positions on multiple characteristics to determine inclusion in the overall portfolio. The Adviser establishes price targets for each position, which are updated frequently. The Adviser monitors these positions and will seek to sell or cover a position when it believes that the security no longer has an attractive risk/return profile. The Adviser will maintain a diversified orientation and seek to construct a portfolio that has less volatility than the U.S. equity markets in general. Further, under normal circumstances, it is expected that the Fund’s long positions will not exceed approximately 125% of the Fund’s net assets. The dollar amount of short sales at any one time (not including short sales against the box) may not exceed 100% of the net assets of the Fund, and it is expected that normally the dollar amount of such sales will not exceed 95% of the net assets of the Fund.

The Fund may invest in equity securities of any type and across all market capitalizations. Equity securities in which the Fund may invest may include exchange-traded and over-the-counter common and preferred stocks, warrants, rights, convertible securities, depositary receipts, limited partnership interests, shares of other investment companies, including exchange-traded funds, and real estate investment trusts (“REITs”). The Fund may invest, from time to time, a significant portion of its assets in smaller issuers which are more volatile and less liquid than investments in issuers with larger market capitalizations. The Fund’s long and short positions may involve (without limit) equity securities of foreign issuers that are traded in the markets of the United States, either directly or through American Depositary Receipts (“ADRs”), European Depository Receipts (“EDRs”), Global Depositary Receipts (“GDRs”) or International Depositary Receipts (“IDRs”). The Fund may also invest up to 35% of its total assets directly in equity securities of foreign issuers that are traded outside of the United States. In general, the Fund’s investments are broadly diversified over a number of industries and, as a matter of policy, the Fund is limited to investing less than 25% of its total assets in any one industry.

The Fund may invest in securities of companies operating less than three years (“unseasoned issuers”) and in initial public offerings (“IPO”) of securities.

The Fund may invest up to 20% of its net assets in high yield debt obligations, such as bonds and debentures, used by corporations and other business organizations. High yield debt obligations are referred to as “junk bonds” and are not considered to be investment grade. The Fund may invest up to 15% of its net assets in illiquid securities, including securities that are illiquid by virtue of the absence of a readily available market or legal or contractual restrictions on resale.

The Fund may achieve certain investment exposures, including short positions, through derivative transactions, including options on securities and options on indices. The Fund may use derivatives to enhance total return or to hedge against fluctuations in securities prices and currency exchange rates. When the Fund enters into derivative transactions, it may be required to segregate assets, or enter into offsetting positions, in accordance with applicable regulations.

Read More

BIVRX - Performance

Return Ranking - Trailing

Period BIVRX Return Category Return Low Category Return High Rank in Category (%)
YTD -6.8% -10.3% 17.3% 98.83%
1 Yr -2.7% -13.1% 44.0% 98.25%
3 Yr 24.7%* -21.2% 30.6% 3.97%
5 Yr 25.2%* -4.2% 25.2% 1.45%
10 Yr N/A* -4.2% 9.9% N/A

* Annualized

Return Ranking - Calendar

Period BIVRX Return Category Return Low Category Return High Rank in Category (%)
2023 -3.4% -17.3% 43.8% 91.23%
2022 16.0% -54.0% 17.4% 2.56%
2021 40.2% -40.0% 54.1% 4.00%
2020 7.8% -47.6% 88.4% 32.64%
2019 7.8% -20.3% 62.6% 61.76%

Total Return Ranking - Trailing

Period BIVRX Return Category Return Low Category Return High Rank in Category (%)
YTD -6.8% -10.3% 17.3% 98.83%
1 Yr -2.7% -13.1% 44.0% 98.25%
3 Yr 24.7%* -21.2% 30.6% 3.97%
5 Yr 25.2%* -4.2% 25.2% 1.45%
10 Yr N/A* -4.2% 9.9% N/A

* Annualized

Total Return Ranking - Calendar

Period BIVRX Return Category Return Low Category Return High Rank in Category (%)
2023 16.2% -14.5% 43.8% 18.13%
2022 49.5% -54.0% 50.3% 1.92%
2021 61.2% -40.0% 61.6% 2.00%
2020 11.2% -29.9% 91.0% 31.94%
2019 11.3% -17.9% 79.4% 53.68%

NAV & Total Return History


BIVRX - Holdings

Concentration Analysis

BIVRX Category Low Category High BIVRX % Rank
Net Assets 1.44 B 1.04 M 6.15 B 4.65%
Number of Holdings 379 2 1788 14.20%
Net Assets in Top 10 400 M 474 K 1.98 B 11.83%
Weighting of Top 10 25.95% 0.4% 101.9% 81.07%

Top 10 Holdings

  1. COMCAST CORP-A 3.10%
  2. VERIZON COMMUNIC 3.08%
  3. ATT INC 2.95%
  4. ZOOM VIDEO COM-A 2.50%
  5. PENN ENTERTAINME 2.49%
  6. EXPEDIA GROUP IN 2.43%
  7. VIATRIS INC 2.43%
  8. SSC TECHNOLOGIE 2.35%
  9. LYFT INC-A 2.34%
  10. EBAY INC 2.29%

Asset Allocation

Weighting Return Low Return High BIVRX % Rank
Cash
79.03% 0.00% 102.08% 13.61%
Stocks
20.55% 0.00% 102.24% 80.47%
Preferred Stocks
0.22% 0.00% 8.72% 11.83%
Other
0.20% -45.12% 99.51% 36.69%
Convertible Bonds
0.00% -0.02% 4.48% 95.09%
Bonds
0.00% 0.00% 95.60% 97.04%

Stock Sector Breakdown

Weighting Return Low Return High BIVRX % Rank
Technology
18.28% 0.00% 43.24% 48.59%
Healthcare
15.31% 0.00% 100.00% 44.37%
Consumer Cyclical
13.64% 0.00% 88.83% 20.42%
Consumer Defense
10.97% 0.00% 33.38% 14.79%
Basic Materials
10.30% 0.00% 28.58% 7.75%
Communication Services
9.86% 0.00% 32.32% 14.79%
Industrials
8.69% 0.00% 31.93% 59.15%
Financial Services
6.23% 0.00% 83.83% 84.51%
Energy
5.44% 0.00% 32.57% 36.62%
Utilities
1.18% 0.00% 21.71% 59.86%
Real Estate
0.11% 0.00% 10.93% 74.65%

Stock Geographic Breakdown

Weighting Return Low Return High BIVRX % Rank
US
13.70% 0.00% 102.24% 79.88%
Non US
6.85% -3.09% 67.69% 11.24%

BIVRX - Expenses

Operational Fees

BIVRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 3.33% 0.42% 8.51% 9.30%
Management Fee 1.74% 0.00% 2.50% 91.28%
12b-1 Fee 0.25% 0.00% 1.00% 70.53%
Administrative Fee N/A 0.03% 1.54% N/A

Sales Fees

BIVRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 4.00% N/A

Trading Fees

BIVRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 1.00% 0.50% 2.00% 80.95%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIVRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 179.00% 0.00% 479.00% 65.19%

BIVRX - Distributions

Dividend Yield Analysis

BIVRX Category Low Category High BIVRX % Rank
Dividend Yield 0.00% 0.00% 26.99% 1.17%

Dividend Distribution Analysis

BIVRX Category Low Category High Category Mod
Dividend Distribution Frequency None Annually Quarterly Annual

Net Income Ratio Analysis

BIVRX Category Low Category High BIVRX % Rank
Net Income Ratio -1.56% -3.33% 2.16% 81.18%

Capital Gain Distribution Analysis

BIVRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

BIVRX - Fund Manager Analysis

Managers

Ali Motamed


Start Date

Tenure

Tenure Rank

Jun 19, 2017

4.95

5.0%

Prior to founding Invenomic, Ali was Co-Portfolio manager of the Boston Partners Long/Short Equity Fund. He was awarded Portfolio Manager of the Year in the Alternatives Category by Morningstar in 2014. Prior to joining Boston Partners, he was a member of the global mergers and acquisitions teams at Deutsche Bank and BT Wolfensohn. Mr. Motamed holds a B.A. degree in economics with a minor in accounting from the University of California, Los Angeles, and a M.B.A. degree from Harvard Business School. He holds the Chartered Financial Analyst designation.

Benjamin Deschaine


Start Date

Tenure

Tenure Rank

Jun 19, 2017

4.95

5.0%

Benjamin R. Deschaine, Senior Research Analyst of BCM and the Adviser, is a co-portfolio manager of the Fund. Prior to 2012, Mr. Deschaine was a Managing Director at Sabretooth Capital Management, LLC, a global multi-strategy hedge fund affiliated with Tiger Management and a Portfolio Manager and Senior Analyst at Federal Street Advisors

Tenure Analysis

Category Low Category High Category Average Category Mode
0.07 23.55 6.05 7.93